|
Tetramer/BV421 – H-2 Kd HIV gag (AMQMLKETI)
|
|
|
|
Tetramer/BV421 – H-2 Kd MAGE-A3 (SYVKVLHHM)
|
|
|
|
Tetramer/BV421 – HLA-A*02:01IGRP (228-236) (LNIDLLWSV)
|
|
|
|
Tetramer/BV421 – HLA-B*57:01 HIV gag (147-155) (ISPRTLNAW)
|
|
|
|
Tetramer/BV421 – HLA-A*03:01HIV p17 gag (20-28) (RLRPGGKKK)
|
|
|
|
Tetramer/PE – HLA-A*02:01Mesothelin (20-28) (SLLFLLFSL)
|
|
|
|
Tetramer/BV421 – H-2 Kb LCMV (LEYDFNKL)
|
|
|
|
Tetramer/BV421 – HLA-A*0101 CMV (VTEHDTLLY)
|
|
|
|
Tetramer/BV421 – HLA-A*2402 CMV (QYDPVAALF)
|
|
|
|
Tetramer/BV421 – HLA-A*02:01Insulin B.10 (HLVEALYLV)
|
|
|
|
Tetramer/PE – HLA-A*02:01 Tyrosinase (YMDGTMSQV)
|
|
|
|
Tetramer/BV421 – HLA-A*02:01MAGE-A10 (GLYDGMEHL)
|
|
|
|
Tetramer/BV421 – H-2 Kb LCMV (ISHNFCNL)
|
|
|
|
Tetramer/PE – H-2 Db MHV S protein (510-518) (CSLWNGPHL)
|
|
|
|
Tetramer/BV421 – HLA-A*02:01 WT-1 (RMFPNAPYL)
|
|
|
|
Tetramer/BV421 – HLA-B*0702 CMV (TPRVTGGGAM)
|
|
|
|
Tetramer/PE – HLA-A*03:01EBV EBNA3A (603-611) (RLRAEAQVK)
|
|
|
|
Tetramer/BV421 – HLA – A*02:01 Melanoma – KTWGQYWQV
|
|
|
|
Tetramer/BV421 – HLA-A*0201 Influenza-M1 (GILGFVFTL)
|
|
|
|
Tetramer/BV421 – Mafa-B*104:01 SIV nef LT9 (LNMADKKET)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 Tyrosinase (YMDGTMSQV)
|
|
|
|
Tetramer/BV421 – HLA-B*27:05 NP(383-391) (SRYWAIRTR)
|
|
|
|
Tetramer/PE – HLA – B*15:01EBNA4 (GQGGSPTAM)
|
|
|
|
Tetramer/BV421 – HLA-A*02:01EBV LMP2 (426-434) (CLGGLLTMV)
|
|
|
|
Tetramer/BV421 – Mafa-A1*063 SIV nef HW8 (HPAQTSQW)
|
|
|
|
Tetramer/BV421 – HLA-A*02:01 HIV gag (SLYNTVATL)
|
|
|
|
Tetramer/PE – HLA-A*02:01EBV LMP2 (426-434) (CLGGLLTMV)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 Gp100 (IMDQVPFSV)
|
|
|
|
Tetramer/PE – H-2 Kb Survivin (MFFCFKEL)
|
|
|
|
Tetramer/BV421 – H-2 Kd RSV M2 (SYIGSINNI)
|
|
|
|
Tetramer/BV421 – HLA – A*02:01 MAGE-A1 (KVLEYVIKV)
|
|
|
|
Tetramer/BV421 – HLA-A*03:01Survivin (18-27)(modK) (RISTFKNWPK)
|
|
|
|
Tetramer/PE – H-2 Kb VACV B8R (TSYKFESV)
|
|
|
|
Tetramer/BV421 – HLA-A*02:01Mesothelin (530-538) (VLPLTVAEV)
|
|
|
|
Tetramer/BV421 – HLA – A*02:01 HCV NS3 (CINGVCWTV)
|
|
|
|
Tetramer/BV421 – Mafa-A1*063 SIV nef RM9 (RPKVPLRTM)
|
|
|
|
Tetramer/BV421 – H-2 Db SV40 large T Ag 206-215 (SAINNYAQKL)
|
|
|
|
Tetramer/PE – HLA-A*02:01IGRP (228-236) (LNIDLLWSV)
|
|
|
|
Tetramer/BV421 – H-2 Kb LCMV (AVYNFATC)
|
|
|
|
Tetramer/PE – HLA-A*03:01Influenza Virus NP (265-274) (ILRGSVAHK)
|
|
|
|
Tetramer/BV421 – H-2 Kb TRP2 (SVYDFFVWL)
|
|
|
|
Tetramer/BV421 – HLA-A*02:01 NY-ESO-1 C9V (SLLMWITQV)
|
|
|
|
Tetramer/PE – H-2 Kb Toxoplasma gondii tgd057 (SVLAFRRL)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 Mart-1 (ELAGIGILTV)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 NY-ESO-1 (SLLMWITQC)
|
|
|
|
Tetramer/PE – HLA-A*02:01hTERT D988Y (YLQVNSLQTV)
|
|
|
|
Tetramer/BV421 – H-2 Kb Toxoplasma gondii tgd057 (SVLAFRRL)
|
|
|
|
Tetramer/PE – HLA-A*02:01hTERT Y572 (YLFFYRKSV)
|
|
|
|
Tetramer/BV421 – H-2 Kb LCMV (AVYNFATCGI)
|
|
|
|
Tetramer/BV421 – HLA-A*03:01EBV EBNA3A (603-611) (RLRAEAQVK)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 CMV PP65 (NLVPMVATV)
|
|
|
|
Tetramer/BV421 – Mafa-B*104:01 SIV gag NA9 (NCVGDHQAA)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 HBV core (FLPSDFFPSV)
|
|
|
|
Tetramer/BV421 – HLA-A*24:02 WT1 (mutant) (CYTWNQMNL)
|
|
|
|
Tetramer/BV421 – H-2 Kb Survivin (MFFCFKEL)
|
|
|
|
Tetramer/BV421 – HLA-A*02:01Mesothelin (20-28) (SLLFLLFSL)
|
|
|
|
Tetramer/PE – H-2 Kd Plasmodium CSP (280-288) (SYVPSAEQI)
|
|
|
|
Tetramer/BV421 -Qa-1b Qdm (AMAPRTLLL)
|
|
|
|
Tetramer/PE – HLA-A*02:01Mesothelin (530-538) (VLPLTVAEV)
|
|
|
|
Tetramer/BV421 – H-2 Kb OVA (SIINFEKL)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 HIV pol (ILKEPVHGV)
|
|
|
|
Tetramer/BV421 – HLA-A*03:01htert K973 (KLFGVLRLK)
|
|
|
|
Tetramer/PE – H-2 Kd MAGE-A3 (SYVKVLHHM)
|
|
|
|
Tetramer/BV421 – HLA-B*0801 CMV (ELRRKMMYM)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 Her-2/neu (KIFGSLAFL)
|
|
|
|
Tetramer/PE – HLA-A*02:01MAGE-A10 (GLYDGMEHL)
|
|
|
|
Tetramer/PE – HLA-A*03:01htert K973 (KLFGVLRLK)
|
|
|
|
Tetramer/BV421 – H-2 Kb LCMV (YTVKYPNL)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 Gp 100 (ITDQVPFSV)
|
|
|
|
Tetramer/BV421 – HLA-A*03:01 (20-28) EBV BRLF1 (RVRAYTYSK)
|
|
|
|
Tetramer/BV421 – Mamu-A*01 SIV gag (CTPYDINQM)
|
|
|
|
Tetramer/BV421 – HLA-A*02:01hTERT Y572 (YLFFYRKSV)
|
|
|
|
Tetramer/BV421 – HLA-A*2402 HBV core (EYLVSFGVW)
|
|
|
|
Tetramer/BV421 – H-2 Kd Plasmodium CSP (280-288) (SYVPSAEQI)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 Her-2/neu (RLLQETELV)
|
|
|
|
Tetramer/BV421 – HLA-A*2402 HBV pol (KYTSFPWLL)
|
|
|
|
Tetramer/BV421 – H-2 Kb VACV B8R (TSYKFESV)
|
|
|
|
Tetramer/BV421 – HLA-B*27:05 HIV gag (263-272) (KRWIIMGLNK)
|
|
|
|
Tetramer/BV421 – Mafa-A1*063 SIV gag GW9 (GPRKPIKCW)
|
|
|
|
Tetramer/BV421 – H-2 Kd Fibrosarcoma neoepitope Tnpo3 (SYMLQALCI)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 PR-1 (VLQELNVTV)
|
|
|
|
Tetramer/BV421 – HLA-A*02:01hTERT D988Y (YLQVNSLQTV)
|
|
|
|
Tetramer/BV421 – HLA-A*03:01Influenza Virus NP (265-274) (ILRGSVAHK)
|
|
|
|
Tetramer/PE – H-2 Kd Fibrosarcoma neoepitope Tnpo3 (SYMLQALCI)
|
|
|
|
Tetramer/BV421 – HLA-A*01:01 MAGE-A3 (EVDPIGHLY)
|
|
|
|
Tetramer/PE – HLA-A*03:01HIV p17 gag (20-28) (RLRPGGKKK)
|
|
|
|
Tetramer/BV421 – H-2 Db SIV GAG (AAVKNWMTQTL)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 HTLV-1 (LLFGYPVYV)
|
|
|
|
Tetramer/PE – HLA-A*02:01Insulin B.10 (HLVEALYLV)
|
|
|
|
Tetramer/BV421 – HLA – B*15:01EBNA4 (GQGGSPTAM)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 EBV (GLCTLVAML)
|
|
|
|
Tetramer/BV421 – HLA-A*0201 HPV (YMLDLQPET)
|
|
|
|
Tetramer/PE – HLA-A*03:01Survivin (18-27)(modK) (RISTFKNWPK)
|
|
|
|
Tetramer/BV421 – HLA-B*3501 CMV (IPSINVHHY)
|
|
|
|
Tetramer/PE – Mafa-A1*063 SIV nef HW8 (HPAQTSQW)
|
|
|
|
Tetramer/PE – HLA-B*27:05 HIV gag (263-272) (KRWIIMGLNK)
|
|
|
|
Tetramer/PE – HLA-B*27:05 NP(383-391) (SRYWAIRTR)
|
|
|
|
Tetramer/PE – HLA-A*24:02 WT1 (mutant) (CYTWNQMNL)
|
|
|
|
Tetramer/PE – Mafa-A1*063 SIV gag GW9 (GPRKPIKCW)
|
|
|
|
Tetramer/PE – HLA-B*57:01 HIV gag (147-155) (ISPRTLNAW)
|
|
|